Indonesia’s Kalbe Farma Cuts Remdesivir Price for Hospitals

(Bloomberg) -- Indonesian pharmaceutical company PT Kalbe Farma reduced the price of remdesivir by half as the country grapples with surging coronavirus infections.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.